NCT04160117 - Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot) | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions

Atrial FibrillationRecurrence

Interventions

DRUG

Colchicine 0.6 mg

p.o. twice daily for 10 days after catheter ablation for atrial fibrillation

DRUG

Matching placebo

p.o. twice daily for 10 days after catheter ablation for atrial fibrillation

Trial Locations (1)

Hamilton Health Sciences Corporation - Hamilton General Hospital, Hamilton